LY3303560

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for LY3303560, covering 2022-08-30 to 2023-10-10. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY3303560 in Participants With Mild Cognitive Impairment or Alzheimer's Disease [Phase 1]